Exact Mass: 323.0827

Exact Mass Matches: 323.0827

Found 74 metabolites which its exact mass value is equals to given mass value 323.0827, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

NSK-850

Thenylchlor

C16H18ClNO2S (323.0747)


   

Myo-inositol glutamate

3-amino-7a,8,9,10,11,11a-hexahydroxy-hexahydro-3H-1,7-benzodioxonine-2,6-dione

C11H17NO10 (323.0852)


   

58F70VH0HS

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H17NO4.HCl (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Lycorine

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H17NO4.HCl (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Aristoliukine C

Aristoliukine C

C18H13NO5 (323.0794)


   

Norfissilandione

1,2-(Methylenedioxy)-9-methoxy-8,11-dioxo-6a,7-dehydroaporphine

C18H13NO5 (323.0794)


   

9-Methoxyaristolactam I

9-Methoxyaristololactam I

C18H13NO5 (323.0794)


   

Oxosarcophylline

Oxosarcophylline

C18H13NO5 (323.0794)


   

Decumbenine B

Decumbenine B

C18H13NO5 (323.0794)


   

Oxosarcocapnidine

Oxosarcocapnidine

C18H13NO5 (323.0794)


   

Maybridge3_000330

Maybridge3_000330

C18H13NO5 (323.0794)


   

2-[[bis(4-fluorophenyl)methyl]sulfinyl]-N-methyl-acetamide

2-[[bis(4-fluorophenyl)methyl]sulfinyl]-N-methyl-acetamide

C16H15F2NO2S (323.0792)


   
   

Maybridge3_002649

Maybridge3_002649

C18H13NO5 (323.0794)


   
   
   
   
   

7,8-Dimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

7,8-Dimethoxybenzo[f]-1,3-benzodioxolo[6,5,4-cd]indol-5(6H)-one

C18H13NO5 (323.0794)


   

oxocularidine

oxocularidine

C18H13NO5 (323.0794)


   

Lycorine HCl

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H18ClNO4 (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   
   
   
   
   
   
   
   
   

1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol

1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol

C17H13N3O4 (323.0906)


   

4-BENZOYLBENZOIC ACID SUCCINIMIDYL ESTER

4-BENZOYLBENZOIC ACID SUCCINIMIDYL ESTER

C18H13NO5 (323.0794)


   

7-methoxy-8-methyl-2-[3-(trifluoromethyl)pyrazol-1-yl]-1H-quinolin-4-one

7-methoxy-8-methyl-2-[3-(trifluoromethyl)pyrazol-1-yl]-1H-quinolin-4-one

C15H12F3N3O2 (323.0882)


   

MOLYBDENUM V ETHOXIDE

MOLYBDENUM V ETHOXIDE

C10H25MoO5 (323.0756)


   

14H-benzo[c]benzo[4,5]thieno[2,3-a]carbazole

14H-benzo[c]benzo[4,5]thieno[2,3-a]carbazole

C22H13NS (323.0769)


   

5H--Benzo-a-1-benzothieno-3-2--c-carbazole

5H--Benzo-a-1-benzothieno-3-2--c-carbazole

C22H13NS (323.0769)


   

5-(Diethylsulfamoyl)-3-hydroxynaphthalene-2-carboxylic acid

5-(Diethylsulfamoyl)-3-hydroxynaphthalene-2-carboxylic acid

C15H17NO5S (323.0827)


   

Ethyl 5-hydroxy-1,2-dimethyl-4,6-dinitroindole-3-carboxylate

Ethyl 5-hydroxy-1,2-dimethyl-4,6-dinitroindole-3-carboxylate

C13H13N3O7 (323.0753)


   

3-[(5,6-Dimethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

3-[(5,6-Dimethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

C16H13N5OS (323.0841)


   

N-(2-tert-butyl-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl)-2-thiophenecarboxamide

N-(2-tert-butyl-5-oxo-4,6-dihydrothieno[3,4-c]pyrazol-3-yl)-2-thiophenecarboxamide

C14H17N3O2S2 (323.0762)


   

3-[(6-Ethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

3-[(6-Ethyl-4-thieno[2,3-d]pyrimidinyl)hydrazo]-2-indolone

C16H13N5OS (323.0841)


   

5-amino-7a,8,9,10,11,11a-hexahydroxy-4,5,8,9,10,11-hexahydro-3H-benzo[b][1,4]dioxonine-2,6-dione

5-amino-7a,8,9,10,11,11a-hexahydroxy-4,5,8,9,10,11-hexahydro-3H-benzo[b][1,4]dioxonine-2,6-dione

C11H17NO10 (323.0852)


   

3-[4-(2-Furanylmethyl)-5-sulfanylidene-1,2,4-triazolidin-3-ylidene]-2-naphthalenone

3-[4-(2-Furanylmethyl)-5-sulfanylidene-1,2,4-triazolidin-3-ylidene]-2-naphthalenone

C17H13N3O2S (323.0728)


   

3-Pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester

3-Pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester

C17H13N3O4 (323.0906)


   

1-Ethyl-3-[[2-[(1-methyl-2-benzimidazolyl)thio]-1-oxoethyl]amino]thiourea

1-Ethyl-3-[[2-[(1-methyl-2-benzimidazolyl)thio]-1-oxoethyl]amino]thiourea

C13H17N5OS2 (323.0874)


   

2-(4-methyl-1-piperazinyl)-N-(5-thiophen-2-yl-1,3,4-thiadiazol-2-yl)acetamide

2-(4-methyl-1-piperazinyl)-N-(5-thiophen-2-yl-1,3,4-thiadiazol-2-yl)acetamide

C13H17N5OS2 (323.0874)


   

N-benzoyl-2-phenyl-4-thiazolecarbohydrazide

N-benzoyl-2-phenyl-4-thiazolecarbohydrazide

C17H13N3O2S (323.0728)


   

2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide

2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide

C16H18ClNO4 (323.0924)


   
   
   
   
   
   
   

(2S)-2-(2-chloro-7-methylquinolin-3-yl)-2,3-dihydro-1H-quinazolin-4-one

(2S)-2-(2-chloro-7-methylquinolin-3-yl)-2,3-dihydro-1H-quinazolin-4-one

C18H14ClN3O (323.0825)


   

SCH-23390 (hydrochloride)

SCH-23390 (hydrochloride)

C17H19Cl2NO (323.0844)


SCH-23390 hydrochloride (R-(+)-SCH-23390 hydrochloride) is a potent and selective dopamine D1-like receptor antagonist with Kis of 0.2 nM and 0.3 nM for the D1 and D5 receptor, respectively. SCH-23390 hydrochloride is a potent and high efficacy human 5-HT2C receptor agonist with a Ki of 9.3 nM. SCH-23390 hydrochloride also binds with high affinity to the 5-HT2 and 5-HT1C receptors. SCH-23390 hydrochloride inhibits G protein-coupled inwardly rectifying potassium (GIRK) channels with an IC50 of 268 nM[1][2][3].

   

17-hydroxy-4,5-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

17-hydroxy-4,5-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

C18H13NO5 (323.0794)


   

(12r)-18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

(12r)-18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

C18H13NO5 (323.0794)


   

6-methoxy-aristoloactam

NA

C18H13NO5 (323.0794)


{"Ingredient_id": "HBIN012515","Ingredient_name": "6-methoxy-aristoloactam","Alias": "NA","Ingredient_formula": "C18H13NO5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31526","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

9-methoxyaristolactam i

NA

C18H13NO5 (323.0794)


{"Ingredient_id": "HBIN014127","Ingredient_name": "9-methoxyaristolactam i","Alias": "NA","Ingredient_formula": "C18H13NO5","Ingredient_Smile": "COC1=CC=CC2=C3C4=C(C(=C21)OC)NC(=O)C4=CC5=C3OCO5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13835","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

12,14-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

12,14-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C18H13NO5 (323.0794)


   

5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

14,15-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

14,15-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C18H13NO5 (323.0794)


   

(10r)-4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

(10r)-4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

15-hydroxy-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione

15-hydroxy-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-11,12-dione

C18H13NO5 (323.0794)


   

4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

18-hydroxy-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,14,16,18-heptaen-13-one

C18H13NO5 (323.0794)


   

(5-{2h-[1,3]dioxolo[4,5-f]isoquinolin-8-yl}-2h-1,3-benzodioxol-4-yl)methanol

(5-{2h-[1,3]dioxolo[4,5-f]isoquinolin-8-yl}-2h-1,3-benzodioxol-4-yl)methanol

C18H13NO5 (323.0794)


   

17-hydroxy-5,6-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,10,12,14,16-octaen-9-one

17-hydroxy-5,6-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(18),3(8),4,6,10,12,14,16-octaen-9-one

C18H13NO5 (323.0794)


   

2-(hydroxymethyl)-11-iminobenzo[b]fluorene-4,5,9,10-tetrol

2-(hydroxymethyl)-11-iminobenzo[b]fluorene-4,5,9,10-tetrol

C18H13NO5 (323.0794)


   

14,16-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

14,16-dimethoxy-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,9,11,13(18),14,16-octaen-9-ol

C18H13NO5 (323.0794)


   

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),12,14(19),16-hexaene-15,18-dione

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),12,14(19),16-hexaene-15,18-dione

C18H13NO5 (323.0794)


   

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione

16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione

C18H13NO5 (323.0794)


   

4-hydroxy-5,17-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

4-hydroxy-5,17-dimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

C18H13NO5 (323.0794)


   

(10s)-5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

(10s)-5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)